Received by email:

File: XCX_news release_stock options_08may19.pdf

                            Chinook Announces Stock Option Grant

BERLIN, Germany, May 8th, 2019   Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX)
(FSE: C4T), has granted incentive stock options to purchase up to 1,020,000 common shares of
Chinook to its directors, officers, employees, and consultants in Germany, Switzerland and Canada
pursuant to its stock option plan, including 655,000 options issued to directors and officers. Each
option vests immediately, has an exercise price of $0.15 per share and is valid for a period of one
year from the date of issuance.




Chinook Tyee Industry Limited
Chinook is a Berlin based investment company with two European subsidiaries, AMP Alternative
Medical Products GmbH (AMP Germany) and Mercury Partners & Company plc. AMP Germany
plans to import pharmaceutical grade (EU-GMP) cannabis produced by Canadian licensed
producers into Germany. AMP Germany, in cooperation with its business partners, will provide
EU-GMP audit, logistical, transportation, importation and other related services for the importation
of medical cannabis into Germany. Mercury Partners & Company plc is a Malta based investment
holding company that invests mainly in German distressed assets. Chinook has 10,217,796 shares
outstanding and trades on the TSX Venture Exchange (symbol: "XCX") and the Frankfurt Stock
Exchange (symbol: "C4T"). www.amp-eu.com.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in
the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of
this release.

For further information, please contact:

Canada
Mr. Alex Blodgett, Director
Tel: +1 (236) 833-1602
Email: investor@amp-eu.com

Germany
Email: investor@amp-eu.de

Social media links: Twitter, Reddit, LinkedIN

SOURCE Chinook Tyee Industry Limited